Methyl 3-Amino-4-chlorothiophene-2-carboxylate - CAS 632356-41-3
Catalog: |
BB060316 |
Product Name: |
Methyl 3-Amino-4-chlorothiophene-2-carboxylate |
CAS: |
632356-41-3 |
Synonyms: |
3-Amino-4-chlorothiophen-2-carboxylic acid methyl ester |
IUPAC Name: | methyl 3-amino-4-chlorothiophene-2-carboxylate |
Description: | Methyl 3-Amino-4-chlorothiophene-2-carboxylate is a useful research chemical used in the of thiophene derivatives as protein tyrosine phosphatase 1B (PTP1B) inhibitors. |
Molecular Weight: | 191.64 |
Molecular Formula: | C6H6NO2SCl |
Canonical SMILES: | COC(=O)C1=C(C(=CS1)Cl)N |
InChI: | InChI=1S/C6H6ClNO2S/c1-10-6(9)5-4(8)3(7)2-11-5/h2H,8H2,1H3 |
InChI Key: | UGZKUKBGCABYDB-UHFFFAOYSA-N |
References: | Wan, Z., et al. Bioorganic Med. Chem. Lett. 17, 10, 2913-20, (2007). |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021133915-A1 | Ectonucleotide pyrophosphatase/phosphodiesterase 1 (enpp1) modulators and uses thereof | 20191223 |
WO-2020167628-A1 | Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia | 20190213 |
AU-2020222881-A1 | Thioeno(3,2-b) pyridin-7-amine compounds for treating familial dysautonomia | 20190213 |
CA-3129067-A1 | Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia | 20190213 |
IL-285399-D0 | Theano compounds [2,3-b] pyridine-7-amine for the treatment of familial dysautonomia | 20190213 |
CN-113795304-A | Thieno [3,2-B ] pyridin-7-amine compounds for the treatment of familial autonomic nervous dysfunction | 20190213 |
EP-3924049-A1 | Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia | 20190213 |
KR-20210137040-A | Thioeno[3,2-B]pyridin-7-amine compound for the treatment of familial ataxia | 20190213 |
AU-2004272225-A1 | Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same | 20030908 |
CA-2537695-A1 | Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same | 20030908 |
Complexity: | 167 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 190.9807773 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 190.9807773 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 80.6Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.3 |
-
Catalog: BB055796
(-)-(1S,2R)-1,2-Dihydro-1,2-naphthalenediol
Detail
-
Catalog: BB055501
(-)-Camphenilone
Detail
-
Catalog: BB069468
(+)-(S,S,S)-Ciramadol
Detail
-
Catalog: BB069213
(-)-(18-Crown-6)-2,3,11,12-tetracarboxamide
Detail
-
Catalog: BB077452
(+)-(1r)-cis-2,2-Dimethyl-3-isopropenylcyclobutanemethanol acetate
Detail
-
Catalog: BB064047
(-)-Huperzine A-d7 major (>90%)
Detail
-
Catalog: BB056914
(-)-(2S,3S)-Viridifloric Acid Acetonide
Detail
-
Catalog: BB062217
((E)-But-2-enyl)malonic Acid Dimethyl Ester
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS